VARIABLE METABOLISM OF PINACIDIL - LACK OF CORRELATION WITH THE DEBRISOQUINE AND TRIMETHYLAMINE C-OXIDATIVE AND N-OXIDATIVE POLYMORPHISMS

被引:5
作者
AYESH, R [1 ]
ALWAIZ, M [1 ]
MCBURNEY, A [1 ]
MITCHELL, SC [1 ]
IDLE, JR [1 ]
WARD, JW [1 ]
SMITH, RL [1 ]
机构
[1] GROBY RD HOSP,DEPT CLIN PHARMACOL,LEICESTER LE3 9QE,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1111/j.1365-2125.1989.tb05389.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:423 / 428
页数:6
相关论文
共 13 条
[1]   A GENETIC-POLYMORPHISM OF THE N-OXIDATION OF TRIMETHYLAMINE IN HUMANS [J].
ALWAIZ, M ;
AYESH, R ;
MITCHELL, SC ;
IDLE, JR ;
SMITH, RL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (05) :588-594
[2]   TRIMETHYLAMINURIA (FISH-ODOR SYNDROME) - A STUDY OF AN AFFECTED FAMILY [J].
ALWAIZ, M ;
AYESH, R ;
MITCHELL, SC ;
IDLE, JR ;
SMITH, RL .
CLINICAL SCIENCE, 1988, 74 (03) :231-236
[3]   METABOLISM OF THE NEW ANTIHYPERTENSIVE AGENT PINACIDIL IN RAT, DOG AND MAN [J].
EILERTSEN, E ;
MAGNUSSEN, MP ;
PETERSEN, HJ ;
RASTRUPANDERSEN, N ;
SORENSEN, H ;
ARRIGONIMARTELLI, E .
XENOBIOTICA, 1982, 12 (03) :187-196
[4]   PHARMACOKINETICS AND DISTRIBUTION OF THE NEW ANTIHYPERTENSIVE AGENT PINACIDIL IN RAT, DOG AND MAN [J].
EILERTSEN, E ;
HART, JW ;
MAGNUSSEN, MP ;
SORENSEN, H ;
ARRIGONIMARTELLI, E .
XENOBIOTICA, 1982, 12 (03) :177-185
[5]   A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].
EVANS, DAP ;
MAHGOUB, A ;
SLOAN, TP ;
IDLE, JR ;
SMITH, RL .
JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105
[6]   DIFFERENTIATION OF VARIOUS TYPES OF BIOLOGICAL OXIDATION OF NITROGEN IN ORGANIC COMPOUNDS [J].
GORROD, JW .
CHEMICO-BIOLOGICAL INTERACTIONS, 1973, 7 (05) :289-303
[7]   STUDIES ON MECHANISM OF HEPATIC MICROSOMAL N-OXIDE FORMATION - ROLE OF CYTOCHROME-P-450 AND MIXED-FUNCTION AMINE OXIDASE IN N-OXIDATION OF NN-DIMETHYLANILINE [J].
HLAVICA, P ;
KEHL, M .
BIOCHEMICAL JOURNAL, 1977, 164 (03) :487-496
[8]   POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN [J].
MAHGOUB, A ;
IDLE, JR ;
DRING, LG ;
LANCASTER, R ;
SMITH, RL .
LANCET, 1977, 2 (8038) :584-586
[9]   SERUM CONCENTRATIONS AND URINARY-EXCRETION OF PINACIDIL AND ITS MAJOR METABOLITE, PINACIDIL PYRIDINE-N-OXIDE FOLLOWING IV AND ORAL-ADMINISTRATION IN HEALTHY-VOLUNTEERS [J].
MCBURNEY, A ;
FARROW, PR ;
AINSWORTH, S ;
WARD, JW .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (01) :91-94
[10]   EFFECT OF CIRRHOSIS AND DEBRISOQUIN PHENOTYPE ON THE DISPOSITION AND EFFECTS OF PINACIDIL [J].
SHAHEEN, O ;
PATEL, J ;
AVANT, GR ;
HAMILTON, M ;
WOOD, AJJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (06) :650-655